Ford Motor Co on Friday said the top executive Jim Farley will assume the position of chief operating officer, positioning him as potential heir to Chief Executive Jim Hackett. Farley, president of new businesses, technology and strategy, has been viewed as one of the potential successors to Hackett, who took over in 2017. The news comes three days after Ford offered investors a disappointing 2020 profit outlook. …read more […]
U.S. stock index futures extended losses on Friday after the Labor Department revised some past employment numbers lower, suggesting job growth could significantly slow this year.
U.S. job growth accelerated in January, with unseasonably mild temperatures boosting hiring in weather-sensitive sectors, indicating the economy will probably continue to grow moderately despite a deepening slump in business investment.
The Department of Labor delivered its January jobs report at 8:30 a.m. ET. …read more […]
Credit Suisse’s incoming chief executive, Thomas Gottstein, plans to stick Switzerland’s second-biggest bank on a growth offensive following predecessor Tidjane Thiam’s cost-cutting exercise, he told Reuters on Friday.
Spirit AeroSystems Inc, Boeing Co’s largest supplier, said on Friday it would slash its quarterly dividend to just 1 cent per share as it grapples with the grounding of the planemaker’s 737 MAX jets.
In a newly released interview, National Institutes of Health Director Francis Collins warned that cases of coronavirus are rising quickly, especially in China. …read more […]
Nagging coronavirus worries took a swipe at world markets on Friday but failed to stand in the way of the best week for stocks since June and the strongest for the dollar since August.
Swiss markets watchdog FINMA is still examining corporate governance issues at Credit Suisse after Chief Executive Tidjane Thiam resigned amid a scandal over surveillance of managers, the agency said on Friday.
AbbVie Inc on Friday forecast 2020 earnings above Wall Street estimates as the drugmaker expects growth to be powered by its new treatments for psoriasis and rheumatoid arthritis at a time when sales of its blockbuster drug Humira slow.
The drugmaker expects the two treatments, Skyrizi and Rinvoq, to bring in a combined revenue of about $1.70 billion in 2020. The profit forecast excludes any impact from its $63 billion deal for Botox-maker Allergan Plc , which it expects to close in the first quarter. “The launches of Skyrizi and Rinvoq are going extremely well,” Chief Executive Officer Richard Gonzalez said in a statement. …read more […]
In this article we are going to estimate the intrinsic value of Baidu, Inc. (NASDAQ:BIDU) by taking the expected… …read more […]
Headlines moving the stock market in real time. …read more […]
U.S. interest in Ericsson is logical given that it is one of only a few companies offering a complete portfolio for the rollout of super-fast 5G mobile telecoms networks, Sweden’s Minister for Energy and Digital Development said on Friday.
U.S. stock index futures retreated on Friday following a four-day run this week that lifted the Wall Street’s main indexes to record highs, with attention turning to the crucial monthly jobs report.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
